1. Market Research
  2. > Business Services Market Trends
  3. > Research and Development

How to kick-start your R&D industry analysis using the latest figures

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
1 vote

Topics under Research and Development

Global Research & Development Industry

The global research and development (R&D) industry is included in business services and encompasses three main fields of activity, which are basic research, applied research and development. Two central branches of the industry involve R&D in engineering, physical and life sciences on one hand, and the humanities and social sciences on the other.

R&D involves carrying out creative work to expand the knowledge base, and then use that base to improve existing products and processes and to create new products and processes. Company survival relies on innovation, which is encouraged by R&D. Industrial companies in the US invest an average of almost 4% of revenue in R&D, while in the high technology sector this rises closer to 7%. In the pharmaceutical sector the percentage of revenue dedicated to R&D can be higher, such as Novartis at 15%, Merck & Co at 14% and Ericsson at almost 25%.

Key Market Segments

Technology - Sensors manufacturing is becoming easier in terms of quantity and adaptability as technological advances make it easier to produce more sensors and sensors that can be incorporated into smaller devices. Sensors are vital to the functioning of most electronics-based devices, instruments and equipment used in domains that necessitate measuring. Fuji Keizai USA notes the huge potential for sensor research and development (R&D), encompassing various types of sensors, including extreme temperature sensors, multi-axis sensors, accelerometers, wireless sensors, in vivo sensors, millimeter-wave radar sensors and pressure sensors.

Health - Datamonitor estimates there are more than 135 products being developed in the sector of women’s health, which is a sector that has witnessed a falling off in investment over recent years as other therapy areas promising greater return on investment were favored by the pharmaceutical industry. New therapeutics in women’s health cover a wide range of preclinical and clinical level conditions. The leading segments concern menopausal symptoms and contraceptives. Though endometriosis and uterine fibroids represent appealing markets in the women’s health sector, both innovation and investment remain low. Oral gonadotropin releasing hormone antagonists are likely short-term candidates, and diagnostic and biomarker research is likely to be strong long term. Investment in drug discovery is weak due to a perception of lower return on investment. Patient access is likely to fuel long-term market expansion rather than drug advances. Treatment demand will be fuelled by a widening treatable population, with contraceptives and infertility treatments representing the leading segment.

Pharmaceuticals - The global pharmaceutical industry avails of R&D to assess health technology for new products and to gather the economic analyses necessary for effective decision making. Business Insights points to the importance for pharmaceutical companies of taking HTA requirements for new drugs into account. Prior to the launch of a new product on the market, it is vital for companies to explore factors such as treatment heterogeneity, costs associated with a condition, patient perspectives, unmet needs and existing practices. Throughout phase III trials, data can be gathered to support positive reimbursement decisions. Treatment costs are coming to light more and more often following US healthcare reform. The FDA and Centers for Medicare and Medicaid Services are examining the review process. Kalorama Information estimates the average drug takes up to 15 years at a cost of $1.3 billion to bring to market. There is, therefore, an increasing degree of outsourcing of various development phases, with contract research organizations recording growing demand.

Regional Markets

In 2010, the US Scientific Research and Development industry witnessed a near 5% drop in corporate funding following the economic crisis, reports IBIS World. State investment in R&D similarly decreased due to the difficult economic climate. Nonetheless, overall industry revenue recorded yearly growth in excess of 2% to exceed $85 billion. State funding has traditionally been used for basic research, while corporate and private funding often goes to developmental and experimental research to take basic research further. The latter is perceived as more viable, with private investors more likely to invest in this type of research in hope of greater returns.

Read more »

24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 1 400 reports

Global Research And Development Supply

  • March 2015
    227 pages
  • World  


View report >

Research Center Industry in the US and Mexico

  • November 2015
    33 pages
  • Research Center  

  • United States  


    North America  

View report >

Research And Development Market Analysis in Europe

  • November 2015
    5 pages
  • Research and De  

    R and D  

  • Europe  



View report >

Research And Development Industry in Asia

  • May 2015
    18 pages
  • Research and De  

  • Asia  

    United States  

View report >

Research And Development Industry in Japan

  • January 2014
    10 pages
  • Research and De  

  • Japan  

View report >

Research And Development Industry in Germany

  • July 2015
    25 pages
  • Research and De  

  • Germany  

View report >

Research And Development Industry in the UK

  • January 2016
    37 pages
  • Banking  

  • United Kingdom  


View report >

Research And Development Industry in Canada

  • October 2015
    19 pages
  • Research and De  

  • Canada  

    United States  

View report >

Research And Development Analysis in India

  • April 2015
    37 pages
  • India  



View report >

About 1 900 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 200 - $ 4 500)

Wound Closure and Advanced Wound Care Global Market  – Forecast To 2021

Wound Closure and Advanced Wound Care Global Market – Forecast To 2021

  • $ 4 500
  • Industry report
  • December 2015
  • by IQ4I Research & Consultancy Pvt. Ltd

Wound closure and wound care devices are the medical apparatus used for the closure of the wound by pulling the cut edges of the tissues together or by directly acting on the wounds for better healing. ...

R&d In Physical & Engineering Sciences Lines World Repo ...

February 2016 $ 3 047

Research & Development In The Social Sciences & Humanit ...

February 2016 $ 3 047

Research & Development In The Phys, Engineering & Life ...

February 2016 $ 3 047

Research & Development In Social Sciences & Humanities ...

February 2016 $ 3 047

Scientific Research & Development Service Lines World R ...

February 2016 $ 3 047

Global Epigenetic R&d, Therapies And Diagnostics Indust ...

November 2015 $ 2 800

Strategic Analysis Of Autonomous Vehicle Evolution In A ...

February 2016 $ 2 500

B-cell Non-hodgkin Lymphoma - Pipeline Review, H2 2015

December 2015 $ 2 500

Acute Lung Injury - Pipeline Review, H2 2015

December 2015 $ 2 000

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.